FDA grants fast track status to volixibat

The Food and Drug Administration has granted fast track status to volixibat, an investigational treatment manufactured by Shire. “The FDA’s fast track is a process designed to facilitate the...
Source: Hospitalist News - Category: Hospital Management Source Type: research